These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 25053596
1. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Yan Y, Yang FQ, Zhang HM, Che J, Zheng JH. Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596 [Abstract] [Full Text] [Related]
2. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Wang YL, Yao WJ, Guo L, Xi HF, Li SY, Wang ZM. Int J Clin Exp Pathol; 2015 Oct; 8(1):601-7. PubMed ID: 25755751 [Abstract] [Full Text] [Related]
3. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival. Zhang Y, Li J, Song Y, Chen F, Pei Y, Yao F. Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320 [Abstract] [Full Text] [Related]
4. High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma. Liu Y, Lin L, Huang Z, Ji B, Mei S, Lin Y, Shen Z. Int J Clin Exp Pathol; 2015 Aug; 8(1):622-8. PubMed ID: 25755754 [Abstract] [Full Text] [Related]
5. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma. Zhu Y, Xu L, Zhang J, Xu W, Liu Y, Yin H, Lv T, An H, Liu L, He H, Zhang H, Liu J, Xu J, Lin Z. Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103 [Abstract] [Full Text] [Related]
6. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma. Xue Y, Wu G, Liao Y, Xiao G, Ma X, Zou X, Zhang G, Xiao R, Wang X, Liu Q, Long D, Yang J, Xu H, Liu F, Liu M, Xie K, Huang R. Br J Cancer; 2014 Apr 29; 110(9):2250-60. PubMed ID: 24595000 [Abstract] [Full Text] [Related]
7. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Cao K, Xie D, Cao P, Zou Q, Lu C, Xiao S, Zhou J, Peng X. Oncol Res; 2014 Apr 29; 21(5):271-9. PubMed ID: 24854103 [Abstract] [Full Text] [Related]
8. Flotillin-2 is associated with breast cancer progression and poor survival outcomes. Wang X, Yang Q, Guo L, Li XH, Zhao XH, Song LB, Lin HX. J Transl Med; 2013 Aug 15; 11():190. PubMed ID: 23945257 [Abstract] [Full Text] [Related]
9. Upregulation of centromere protein H is associated with progression of renal cell carcinoma. Wu X, Lin Y, Shi L, Huang Y, Lai C, Wang Y, Zhang M, Wang S, Heng B, Yu G, Du X, Fang L, Fu Y, Chen J, Guo Z, Su Z, Wu S. J Mol Histol; 2015 Oct 15; 46(4-5):377-85. PubMed ID: 26248586 [Abstract] [Full Text] [Related]
10. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance. Lei Y, Geng Z, Guo-Jun W, He W, Jian-Lin Y. Mol Cell Biochem; 2010 Nov 15; 344(1-2):23-31. PubMed ID: 20563741 [Abstract] [Full Text] [Related]
11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M. Dan Med J; 2017 Oct 15; 64(10):. PubMed ID: 28975890 [Abstract] [Full Text] [Related]
12. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy. Liang ZL, Kang K, Yoon S, Huang SM, Lim JS, Kim JM, Lim JS, Lee HJ. Ann Surg Oncol; 2012 Aug 15; 19(8):2763-72. PubMed ID: 22246425 [Abstract] [Full Text] [Related]
13. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM, Yang FQ, Yan Y, Che JP, Zheng JH. Int J Clin Exp Pathol; 2014 Aug 15; 7(9):5801-9. PubMed ID: 25337221 [Abstract] [Full Text] [Related]
14. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma. Zhang M, Lu W, Huang Y, Shi J, Wu X, Zhang X, Jiang R, Cai Z, Wu S. J Mol Histol; 2016 Aug 15; 47(4):421-8. PubMed ID: 27323757 [Abstract] [Full Text] [Related]
15. Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma. Miyata Y, Kanda S, Sakai H, Greer PA. Cancer Sci; 2013 Jun 15; 104(6):681-6. PubMed ID: 23445469 [Abstract] [Full Text] [Related]
16. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Xue S, Li QW, Che JP, Guo Y, Yang FQ, Zheng JH. Int J Clin Exp Pathol; 2015 Jun 15; 8(4):3765-74. PubMed ID: 26097558 [Abstract] [Full Text] [Related]
17. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway. Wang Q, Wu G, Zhang Z, Tang Q, Zheng W, Chen X, Chen F, Li Q, Che X. Int J Oncol; 2018 Nov 15; 53(5):2278-2288. PubMed ID: 30226576 [Abstract] [Full Text] [Related]
18. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma. Yu ZH, Zhang Q, Wang YD, Chen J, Jiang ZM, Shi M, Guo X, Qin J, Cui GH, Cai ZM, Gui YT, Lai YQ. Asian Pac J Cancer Prev; 2013 Nov 15; 14(6):3729-34. PubMed ID: 23886173 [Abstract] [Full Text] [Related]
19. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer. Yang FQ, Yang FP, Li W, Liu M, Wang GC, Che JP, Huang JH, Zheng JH. Int J Clin Exp Pathol; 2014 Nov 15; 7(1):110-22. PubMed ID: 24427331 [Abstract] [Full Text] [Related]
20. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. Sato M, Nakai Y, Nakata W, Yoshida T, Hatano K, Kawashima A, Fujita K, Uemura M, Takayama H, Nonomura N. PLoS One; 2013 Nov 15; 8(9):e74313. PubMed ID: 24073208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]